Publications by authors named "Ching-Fu Chang"

Claim this Profile
V
Validation of WHO 2017 Classification and Identification of Prognostic Factors in Patients with Pancreatic Neuroendocrine Neoplasms: A Real-World Experience in Taiwan.
Wei-Pang Ho, Wen-Chi Chou, Chia-Hsun Hsieh, Ming-Mo Hou, Wen-Chi Shen, Wen-Cheng Chang, Ching-Fu Chang

J Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative effectiveness and safety of enzalutamide versus abiraterone in patients with metastatic castration-resistant prostate cancer: a nationwide registry-based cohort study from Taiwan.
Wen-Kuan Huang, Po-Jung Su, Chun-Chi Chen, Ching-Fu Chang, Shao-Ming Yu, I-Chang Hsieh

J Cancer Res Clin Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The first reported case of effective targeted therapy in extrahepatic cholangiocarcinoma harboring an epidermal growth factor receptor exon 19 deletion.
Ling-Jen Hung, Shih-Chiang Huang, Chih-Wei Wang, Wen-Kuan Huang, Ching-Fu Chang

Histopathology· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline and changes in inflammatory parameters for patients with EGFR-mutated NSCLC treated with afatinib.
Zi-Ting Chang, Ping-Chih Hsu, How-Wen Ko, John Wen-Cheng Chang, Chen-Te Wu, Ching-Fu Chang

Thorac Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Efficacy and Safety of S-1 Monotherapy in Non-Small Cell Lung Cancer Management: Insights From a Multicenter Retrospective Cohort Study.
I-Lin Tsai, Chien-Yu Lin, Po-Lan Su, Chien-Chung Lin, John Wen-Cheng Chang, Ching-Fu Chang

Clin Med Insights Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multivariable model for predicting 5-year survival in patients with EGFR-mutated non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors: a retrospective study.
Qi-An Wang, I-Lin Tsai, Chien-Yu Lin, Po-Lan Su, Chien-Chung Lin, John Wen-Cheng Chang, Ching-Fu Chang

Ther Adv Med Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic landscape and comparative analysis of tissue and liquid-based NGS in Taiwanese anaplastic thyroid carcinoma.
Chun-Nan Yeh, Shu-Fu Lin, Chia-Ling Wu, Miaw-Jene Liou, I-Wen Chen, Ching-Fu Chang

NPJ Precis Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and safety of afatinib, gefitinib, and erlotinib for treatment-naïve elderly patients with epidermal growth factor receptor-mutated advanced non-small-cell lung cancer: a multi-institute retrospective study.
Ling-Jen Hung, Ping-Chih Hsu, Cheng-Ta Yang, Chih-Hsi Scott Kuo, John Wen-Cheng Chang, Ching-Fu Chang

Aging (Albany NY)· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive assessment of pretreatment sarcopenia impacts on patients with EGFR-mutated NSCLC treated with afatinib.
Chen-Te Wu, Ping-Chih Hsu, John Wen-Cheng Chang, Ching-Fu Chang, Chen-Yang Huang

Thorac Cancer· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation and validation of a predictive model for estimating survival among patients with EGFR-mutant non-small cell lung cancer.
Chien-Yu Lin, Yun-Tse Chou, Po-Lan Su, Chien-Chung Lin, John Wen-Cheng Chang, Ching-Fu Chang

Am J Cancer Res· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term use and risk of major adverse cardiac events: Comparing enzalutamide and abiraterone in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer.
Hung-Kai Chen, Po-Jung Su, Yan-Lin Wang, Kai-Cheng Chang, Yu-Li Su, Pei-Hung Chang, Ching-Fu Chang, Yung-Chang Lin, Ying-Hsu Chang

Int J Cancer· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The survival after discontinuation of EGFR-TKIs due to intolerable adverse events in patients with EGFR-mutated non-small cell lung cancer.
John Wen-Cheng Chang, Ching-Fu Chang, Chen-Yang Huang, Cheng-Ta Yang, Chih-Hsi Scott Kuo

Thorac Cancer· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidermal growth factor receptor tyrosine kinase inhibitors for non-small cell lung cancer harboring uncommon EGFR mutations: Real-world data from Taiwan.
John Wen-Cheng Chang, Chen-Yang Huang, Yueh-Fu Fang, Ching-Fu Chang, Cheng-Ta Yang

Thorac Cancer· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential treatment in advanced non-small cell lung cancer harboring EGFR mutations.
Ping-Chih Hsu, John Wen-Cheng Chang, Ching-Fu Chang, Chen-Yang Huang, Cheng-Ta Yang

Ther Adv Respir Dis· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant Chemoradiotherapy Associated with Improved Overall Survival in Resected Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy in Intensity-Modulated Radiotherapy Era.
Wing-Keen Yap, Ming-Chieh Shih, Yu-Chen Chang, Chia-Hsin Lin, Shih-Ming Huang, Ching-Fu Chang

Biomedicines· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of BRAF targeting agents in advanced anaplastic thyroid cancer: a multi-institutional retrospective study in Taiwan.
Ching-Fu Chang, Ming-Han Yang, Jih-Hsiang Lee, Shyang-Rong Shih, Chia-Hung Lin

Am J Cancer Res· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of T790M Mutation Status on Later-Line Osimertinib Treatment in Non-Small Cell Lung Cancer Patients.
Yan-Jei Tang, John Wen-Cheng Chang, Ching-Fu Chang, Chen-Yang Huang, Cheng-Ta Yang

Cancers (Basel)· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic Therapy for Gastrointestinal Stromal Tumor: Current Standards and Emerging Challenges.
Wen-Kuan Huang, Chiao-En Wu, Shang-Yu Wang, Ching-Fu Chang, Wen-Chi Chou

Curr Treat Options Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidermal growth factor receptor tyrosine kinase inhibitors for de novo T790M mutation: A retrospective study of 44 patients.
John Wen-Cheng Chang, Chen-Yang Huang, Yueh-Fu Fang, Ching-Fu Chang, Cheng-Ta Yang

Thorac Cancer· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world Afatinib Outcomes in Advanced Non-small Cell Lung Cancer Harboring Mutations.
Chi-Han Chen, John Wen-Cheng Chang, Ching-Fu Chang, Chen-Yang Huang, Cheng-Ta Yang

Anticancer Res· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk Stratification Using a Novel Nomogram for 2190 EGFR-Mutant NSCLC Patients Receiving the First or Second Generation EGFR-TKI.
John Wen-Cheng Chang, Chen-Yang Huang, Yueh-Fu Fang, Ching-Fu Chang, Cheng-Ta Yang

Cancers (Basel)· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Different Tyrosine Kinase Inhibitors for Treatment of Poor Performance Status Patients with EGFR-Mutated Lung Adenocarcinoma.
Chiao-En Wu, Ching-Fu Chang, Chen-Yang Huang, Cheng-Ta Yang, Chih-Hsi Scott Kuo, John Wen-Cheng Chang

Cancers (Basel)· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-L1 Immunohistochemistry Comparability and Their Correlation with Clinical Characteristics in NSCLC.
Chiao-En Wu, Ching-Fu Chang, Liao Kou-Sheng, Ju Chiang, Shih-Wei Lee

Anal Cell Pathol (Amst)· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility and effectiveness of afatinib for poor performance status patients with EGFR-mutation-positive non-small-cell lung cancer: a retrospective cohort study.
Chiao-En Wu, Ching-Fu Chang, Chen-Yang Huang, Cheng-Ta Yang, Chih-Hsi Scott Kuo, John Wen-Cheng Chang

BMC Cancer· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The association between immune-related adverse events and survival outcomes in Asian patients with advanced melanoma receiving anti-PD-1 antibodies.
Chiao-En Wu, Chan-Keng Yang, Meng-Ting Peng, Pei-Wei Huang, Ching-Fu Chang, John Wen-Cheng Chang

BMC Cancer· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis